未登录

Y

Yi-Hua Jan

molecular medicine

H指数:30

被引数:3,235

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Squalene synthase induces ERα expression via cholesterol supplementation to confer statin resistance in lung cancer cells

角鲨烯合成酶通过补充胆固醇诱导ERα表达，以赋予肺癌细胞他汀耐药性。

Cancer Cell International

IF6

2026-02-130

OAAI

Mechanism of auranofin toxicity: Inhibition of tetrahydrobiopterin metabolism

奥沙拉嗪毒性的机制：四氢生物蝶呤代谢的抑制

Toxicology and Applied Pharmacology

IF3.4

2025-10-250

PRE

Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-03-275

OAAI

Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing

BRITISH JOURNAL OF CANCER

IF6.8

2022-07-1613

OA

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors

TARGETED ONCOLOGY

IF4

2022-06-141

OAAI

Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2022-03-213

OA

Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2021-04-2212

OAAI

Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway

CELL COMMUNICATION AND SIGNALING

IF8.9

2020-10-2118

OAAI

Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway

IF6.4

2020-08-2936

OAAI

Panel-derived tumor mutational burden (TMB) is associated with the response to the immune checkpoint inhibitors (ICIs) in urothelial cancers

CANCER RESEARCH

IF16.6

2020-08-150

PREAI

IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway

IF10.1

2020-08-0116

OAAI

Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis

SCIENTIFIC REPORTS

IF3.9

2019-10-1013

OAAI

A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma

SCIENTIFIC REPORTS

IF3.9

2019-08-2326

OAAI

ATP Synthase Subunit Epsilon Overexpression Promotes Metastasis by Modulating AMPK Signaling to Induce Epithelial-to-Mesenchymal Transition and Is a Poor Prognostic Marker in Colorectal Cancer Patients

JOURNAL OF CLINICAL MEDICINE

IF2.9

2019-07-2117

OAAI

Sulfur Mustard Analog Mechlorethamine (Bis(2-chloroethyl)methylamine) Modulates Cell Cycle Progression via the DNA Damage Response in Human Lung Epithelial A549 Cells

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2019-04-0915

OAAI

Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1 to drive lung adenocarcinoma metastasis

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2019-01-2976

OAAI

Quinone and nitrofurantoin redox cycling by recombinant cytochrome b5 reductase

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2018-11-019

OAAI

Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma

SCIENTIFIC REPORTS

IF3.9

2017-08-2923

OAAI

Diacetyl/L-Xylulose Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2017-06-2618

OAAI

Novel approaches to mitigating parathion toxicity: targeting cytochrome P450-mediated metabolism with menadione

COUNTERMEASURES AGAINST CHEMICAL THREATS II

IF0

2016-07-2122

OAAI